Scarica l'app Stockscreener
91.16
4.70%
-4.2042
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CORT Giù?
Forum
Previsione
Precedente Chiudi:
$95.36
Aprire:
$91.595
Volume 24 ore:
787.23K
Relative Volume:
0.71
Capitalizzazione di mercato:
$9.79B
Reddito:
$769.10M
Utile/perdita netta:
$46.67M
Rapporto P/E:
260.45
EPS:
0.35
Flusso di cassa netto:
$119.79M
1 W Prestazione:
-0.76%
1M Prestazione:
+4.07%
6M Prestazione:
+96.61%
1 anno Prestazione:
+33.07%
Intervallo 1D:
$90.12
$93.35
Intervallo di 1 settimana:
$90.12
$97.63
Portata 52W:
$28.66
$97.63
Corcept Therapeutics Inc Stock (CORT) Company Profile
Nome
Corcept Therapeutics Inc
Settore
Industria
Telefono
650.688.8803
Indirizzo
101 REDWOOD SHORES PARKWAY, REDWOOD CITY
Compare CORT vs VRTX, REGN, ARGX, RVMD, ALNY
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CORT
Corcept Therapeutics Inc
|
91.21 | 10.24B | 769.10M | 46.67M | 119.79M | 0.35 |
VRTX
Vertex Pharmaceuticals Inc
|
479.82 | 121.16B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
669.66 | 68.78B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
894.46 | 57.44B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
187.97 | 40.23B | 742.00K | -1.37B | -1.07B | -7.0731 |
ALNY
Alnylam Pharmaceuticals Inc
|
280.76 | 36.28B | 4.29B | 577.22M | 641.34M | 4.2086 |
Corcept Therapeutics Inc Stock (CORT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-05-13 | Aggiornamento | UBS | Neutral → Buy |
| 2026-03-26 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
| 2025-12-31 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| 2025-12-16 | Iniziato | UBS | Neutral |
| 2025-11-18 | Iniziato | Wolfe Research | Peer Perform |
| 2023-11-06 | Aggiornamento | Truist | Hold → Buy |
| 2023-04-11 | Iniziato | SVB Securities | Market Perform |
| 2023-04-04 | Iniziato | Piper Sandler | Overweight |
| 2023-02-15 | Downgrade | Jefferies | Buy → Hold |
| 2022-08-01 | Downgrade | Truist | Buy → Hold |
| 2022-07-27 | Aggiornamento | Jefferies | Hold → Buy |
| 2022-06-27 | Ripresa | Canaccord Genuity | Buy |
| 2022-02-02 | Iniziato | Canaccord Genuity | Buy |
| 2022-01-28 | Iniziato | Truist | Buy |
| 2020-08-05 | Downgrade | Jefferies | Buy → Hold |
| 2019-09-24 | Iniziato | Jefferies | Buy |
| 2019-09-06 | Iniziato | H.C. Wainwright | Buy |
| 2019-02-04 | Downgrade | B. Riley FBR | Buy → Neutral |
| 2018-08-10 | Reiterato | Stifel | Hold |
| 2018-05-31 | Downgrade | Stifel | Buy → Hold |
| 2018-03-09 | Iniziato | B. Riley FBR, Inc. | Buy |
| 2017-08-31 | Iniziato | Stifel | Buy |
| 2017-02-02 | Iniziato | Ladenburg Thalmann | Buy |
| 2015-04-21 | Iniziato | FBR Capital | Outperform |
| 2014-01-13 | Downgrade | Stifel | Buy → Hold |
| 2013-08-09 | Downgrade | Janney | Buy → Neutral |
| 2013-08-09 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2012-02-21 | Reiterato | JMP Securities | Mkt Outperform |
| 2010-01-06 | Aggiornamento | Ladenburg Thalmann | Neutral → Buy |
| 2008-07-17 | Iniziato | Rodman & Renshaw | Mkt Outperform |
| 2007-06-21 | Aggiornamento | Punk, Ziegel & Co | Mkt Perform → Accumulate |
Mostra tutto
Corcept Therapeutics Inc Borsa (CORT) Ultime notizie
Corcept Therapeutics Inc (CORT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
This Warner Bros Discovery Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Monday - Benzinga
Wolfe Research downgrades Corcept stock on valuation concerns By Investing.com - Investing.com Canada
Corcept Therapeutics (CORT) Lifted Earnings Outlook, Is The Stock Now Overvalued? - Yahoo Finance UK
Corcept Therapeutics (CORT) Is Up 5.3% After Analysts Lift Full-Year Earnings Outlook Significantly - Yahoo Finance UK
Corcept Therapeutics Inc (CORT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
CORT|Corcept Therapeutics Inc|Price:95.330|Chg%:-1.330 - TradingKey
Corcept Therapeutics Inc (CORT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Corcept Therapeutics Inc (CORT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
WDC: Western Digital Corp. Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
Corcept Therapeutics Inc (CORT) Fundamental & Financial Data - Stocktwits
CORT: Corcept Therapeutics Inc Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
Corcept Therapeutics And 2 Other Growth Stocks With Significant Insider Ownership - simplywall.st
Corcept Therapeutics to announce Q2 results on July 29 - scanx.trade
Corcept Therapeutics to Announce Second Quarter Financial Results, Provide Corporate Update and Host Conference Call - Yahoo Finance
Corcept Therapeutics stock hits 52-week high at 95.18 USD By Investing.com - Investing.com Canada
Trump Disclosure Shows Corcept Buy Before FDA Approval - Moomoo
CORT Stock Skyrockets 35% After Early FDA Nod For Ovarian Cancer Drug - Stocktwits
CORT Stock Slips After-Hours On Weak Q4 Print: Retail Is Watching April FDA Meeting For Relacorilant As Next Catalyst - Stocktwits
Corcept Therapeutics(CORT.US) Officer Sells US$3.51 Million in Common Stock - Moomoo
Corcept Therapeutics CFO Mokari sells $3.5m in shares By Investing.com - Investing.com South Africa
Corcept Therapeutics CFO Mokari sells $3.5m in shares - Investing.com
Corcept Therapeutics director Wilson sells $882,985 in common stock By Investing.com - Investing.com UK
Form 4 Corcept Therapeutics Incorporated For: 17 July By Investing.com - Investing.com Canada
Corcept Therapeutics (CORT) director logs 10,000-share indirect sale under 10b5-1 plan - Stock Titan
Corcept Therapeutics (CORT) CFO sells 40,000 shares and exercises options - Stock Titan
Corcept Insider Sells Shares After an FDA Approval and a $1.05 Billion Outlook - Yahoo Finance
Corcept Insider Sells Shares After an FDA Approval and a $1.05 Billion Outlook - The Motley Fool
Corcept Therapeutics Inc (NASDAQ:CORT) Shows Strong Growth Fundamentals and Technical Breakout Setup - ChartMill
CORT Stock Hits Highest Levels In 2026 – Cushing’s Syndrome Drug NDA Resubmission Extends 5-Session Rally - Stocktwits
Fed. Circ. Won't Rethink Corcept Patent Loss In Teva Case - Law360
Corcept Therapeutics: Recent Relacorilant Rejection Aside, A Good News Story For Investors - Seeking Alpha
Corcept Therapeutics : CORT - 24/7 Wall St.
CCORF Maintains Corcept Therapeutics(CORT.US) With Buy Rating, Maintains Target Price $135 - Moomoo
Form 4 Corcept Therapeutics Incorporated For: 8 July By Investing.com - Investing.com Nigeria
Corcept (NASDAQ: CORT) CBO reports 600-share stock gift and holdings - Stock Titan
Corcept Therapeutics CDO William Guyer sells $1.86m in stock - Investing.com
Corcept Therapeutics CDO William Guyer sells $1.86m in stock By Investing.com - Investing.com India
Insider at Corcept (NASDAQ: CORT) sells shares after option exercise - Stock Titan
Form 144 CORCEPT THERAPEUTICS INC For: 7 July By Investing.com - Investing.com Nigeria
William Guyer to sell 20,000 CORT shares (NASDAQ: CORT) via option exercise - Stock Titan
Corcept Therapeutics highlights its endocrine focus as investors watch CORT stock - AD HOC NEWS
CORT News | CORCEPT THERAPEUTICS INC (NASDAQ:CORT) - ChartMill
Corcept (CORT) executive sells 25K shares after exercising options - Stock Titan
CORTCorcept Therapeutics Inc Options - Finviz
Corcept Therapeutics stock hits 52-week high at 91.1 USD By Investing.com - Investing.com Canada
Healthcare Stocks Investors Are Turning To After The Weak US Jobs Report - Sahm
Price to sales forward of Corcept Therapeutics Incorporated – NASDAQ:CORT - TradingView
Price to book forward of Corcept Therapeutics Incorporated – NASDAQ:CORT - TradingView
Corcept Therapeutics Inc Azioni (CORT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.65%
1.25%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):